The Treatment of Obesity in the Context of the Obesity Paradox in Patients with Heart Failure: A Narrative Review
Pamela L Alebna, Sarah Martey, Anurag Mehta, Carl J Lavie, Salvatore Carbone · 2025
Read The Treatment of Obesity in the Context of the Obesity Paradox in Patients with Heart Failure: A Narrative Review by Pamela L Alebna, Sarah Martey, Anurag Mehta, Carl J Lavie, Salvatore Carbone (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12708749.txt.
Description
Pamela Alebna and four co-authors published a 2025 review of treating obesity in heart failure, where heavier patients oddly survive longer, the so-called obesity paradox. Once heart failure sets in, higher body mass seems protective in observational data. The review weighs fitness and lean mass as the deeper drivers behind that pattern, and examines new incretin-based weight-loss drugs.
These drugs cut weight and help some heart failure types, but their role in reduced-function hearts is unsettled. Big weight loss may also burn lean mass, a danger for frail patients. The authors urge judging treatment by fitness, walk capacity, and quality of life, not weight alone. They call for fresh studies matching modern drugs to the right patients.
Catalog record
| CREATOR | Pamela L Alebna, Sarah Martey, Anurag Mehta, Carl J Lavie, Salvatore Carbone |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |